G. Prado, R. W. Cook, K. R. Covington, F. A. Monzon, and D. S. Rigel, “Improvement of risk assessment in cutaneous melanoma (CM) by a prognostic 31-gene expression profile (31-GEP) test over AJCC-based staging alone”, J of Skin, vol. 2, p. S70, Dec. 2018.